Treace Medical Concepts (TMCI)

• Market cap: $452M
• 1 day: -0.97%
• 5 days: -2.85%
• 1 month: 1.56%
• 3 months: 24.13%
• 6 months: -10.29%
• Year to date: -9.15%
• 1 year: 42.71%
• 5 years: -71.99%
• 10 years: -71.99%
• Sector: Healthcare
• Industry: Medical Devices

About: Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Employees: 477

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 40

0.56% more ownership

Funds ownership: 60.51% [Q1] → 61.07% (+0.56%) [Q2]

10% less funds holding

Funds holding: 137 [Q1] → 123 (-14) [Q2]

28% less capital invested

Capital invested by funds: $315M [Q1] → $226M (-$89M) [Q2]

41% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 29

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $6
• Avg. target: $6.83
• High target: $8

3 analyst ratings

• positive: 0 0%
• neutral: 3 100%
• negative: 0 0%

Truist Securities Richard Newitter	$8	Hold Maintained	4 Sep 2025
UBS Danielle Antalffy	$6.5	Neutral Maintained	8 Aug 2025
Stifel Rick Wise	$6	Hold Maintained	8 Aug 2025